Company news
ClearPoint Neuro Inc. news in 2021
ClearPoint Neuro Inc.'s news releases, calls and decks from 2021, newest first.
ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System
November 16, 2021
ClearPoint Neuro Reports Third Quarter 2021 Results
November 8, 2021
ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients
November 7, 2021
ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference
November 3, 2021
Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors
November 1, 2021
ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021
October 25, 2021
ClearPoint Neuro Reports Second Quarter 2021 Results
August 9, 2021
ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG
August 8, 2021
ClearPoint Neuro, Inc. Announces Installation of ClearPoint® Neuro Navigation System at Hôpital Fondation Rothschild in Paris
August 3, 2021
ClearPoint Neuro to Announce Second Quarter 2021 Results August 10, 2021
August 1, 2021
Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution
July 20, 2021
ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors
July 14, 2021
ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland
June 15, 2021
ClearPoint Neuro Set to Join Russell 3000® Index
June 13, 2021
ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease
June 7, 2021
ClearPoint Neuro to Present at the UBS Global Healthcare Virtual Conference
May 18, 2021
ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software
May 17, 2021
ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’
May 10, 2021
ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room
May 9, 2021
ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021
April 28, 2021
ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease
April 27, 2021
ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 22, 2021
ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.
April 12, 2021
ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
April 5, 2021
ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel
March 23, 2021
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
March 3, 2021
ClearPoint Neuro Announces Closing of Public Offering of 2,127,660 Shares of Common Stock
February 22, 2021
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021
February 18, 2021
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
February 17, 2021
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
February 17, 2021
ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock
February 17, 2021
ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems
February 10, 2021
ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher as Chairman of the Board of Directors
February 4, 2021
ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners
January 25, 2021
ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe
January 13, 2021
ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results
January 11, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 28 slides · Nov 9, 2021
- Investor Presentation (August 2021)
Investor deck · 28 slides · Aug 10, 2021
- Investor Presentation (May 2021)
Investor deck · 28 slides · May 25, 2021
- Investor Presentation (May 2021)
Investor deck · 27 slides · May 12, 2021
- Investor Presentation (April 2021)
Investor deck · 13 slides · April 2021
- Investor Presentation (February 2021)
Investor deck · 27 slides · Feb 19, 2021